Tornier Raises $166M Through IPO

The medical device manufacturer will net about $155.4 million, which it will use for general corporate purposes and to repay $115.2 million in debt.

Tornier, an Amsterdam-based medical device company with U.S. headquarters in Edina, has raised $166.3 million through its initial public offering (IPO).

The company-which filed for its IPO last June and is now listed on the Nasdaq Global Market under the symbol “TRNX”-will net about $155.4 million. It plans to use the proceeds for general corporate purposes and to repay $115.2 million in debt.

Shares were priced at $19, which was at the low end of the company's previously announced range of $19 to $21 per share. When the company filed for its IPO, it planned to raise $205 million.

Tornier manufactures joint replacement, trauma, sports medicine, and other products for the medical industry. It was acquired in 2006 by an investor group led by global private-equity firm Warburg Pincus.

Other investors include Eden Prairie-based Split Rock Partners, L.P., and Tornier CEO Douglas Kohrs, who currently works from the company's Edina office.

The state of the economy has resulted in very few Minnesota IPOs in the past few years. In 2010, two companies-SPS Commerce, Inc., and Electromed, Inc.-went public, up from 2009 when one company completed in IPO (AGA Medical Holdings, Inc.) and 2008 when there were no Minnesota companies that went public.

In addition to the two companies that went public in 2010, two others filed for an initial public offering but either haven't yet completed the transaction or withdrew the filing altogether: Minnetonka-based Welsh Property Trust, Inc., and Plymouth-based Kips Bay Medical, Inc.